Indefinite Delivery Contract SPE2DR25D7064

The federal contract IDV award SPE2DR25D7064 is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The original solicitation, issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, aims to establish multiple Prime Vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract covers an extensive array of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The solicitation is an unrestricted, fully competitive acquisition with a Lowest Price Technically Acceptable (LPTA) evaluation approach, and the Government intends to make multiple regional awards to ensure resiliency and access to vital pharmaceuticals.